Data by

Top 25 pharma companies by cardiovascular sales

The rankings of the top 25 pharmaceutical companies in cardiovascular have been compiled from GlobalData's pharmaceutical revenue figures, which are based on sales of prescription medicines, including generics drugs. The rankings include figures for 2014, 2013, 2012 and 2011.

For ease of comparison the rankings, along with those for CNS, immunology, oncology, metabolic, global, US and Japan sales, are also displayed in the Top Pharma List 2012 infographic.

2014
2013
2012

#	Company	2014 ($m)	2013 ($m)	Growth ($m)	Growth (%)
1	AstraZeneca	7657	7723	-66	-1
2	Sanofi	6620	6850	-230	-3
3	Merck & Co.	5230	5794	-564	-10
4	Daiichi Sankyo	4665	5205	-540	-10
5	Pfizer	4125	4603	-478	-10
6	Novartis	3948	5270	-1322	-25
7	Bayer	3868	2800	1068	38
8	Takeda	2457	2324	133	6
9	Boehringer Ingelheim	2418	3314	-896	-27
10	Astellas	2029	2105	-76	-4
11	Actelion	1958	1795	163	9
12	Johnson & Johnson	1522	864	658	76
13	Shionogi	1297	1512	-215	-14
14	United Therapeutics	1280	1107	173	16
15	Bristol-Myers Squibb	1193	635	558	88
16	Gilead Sciences	1105	969	136	14
17	Otsuka	846	817	29	4
18	Roche	796	728	68	9
19	Lilly	705	695	10	1
20	The Medicines Company	674	625	49	8

#	Company	2013 ($m)	2012 ($m)	Growth ($m)	Growth (%)
1	AstraZeneca	7723	8750	-1027	-12
2	Novartis	7215	7476	-261	-3
5	Pfizer	5735	8039	-2304	-29
3	Sanofi	6448	7337	-889	-12
4	Merck & Co.	6129	6576	-447	-7
6	Daiichi Sankyo	4053	4165	-112	-3
7	Boehringer Ingelheim	3926	3509	417	12
24	Bristol-Myers Squibb	635	3052	-2417	-79
12	Astellas	2006	2116	-110	-5
11	GlaxoSmithKline	2144	2266	-122	-5
18	AbbVie	953	2301	-1348	-59
10	Takeda	2500	2428	72	3
9	Bayer	2579	1887	692	37
14	Shionogi	1463	1476	-13	-1
16	United Therapeutics	1107	907	200	22
20	Otsuka	835	808	27	3
17	Gilead Sciences	969	783	186	24
22	Dainippon Sumitomo Pharma	719	755	-36	-5
23	Mitsubishi Tanabe	695	724	-29	-4
21	Roche	728	623	105	17
25	The Medicines Company	625	558	67	12
8	Lilly	3105	2823	282	10
13	Actelion	1794	1743	51	3
15	Biogen Idec	1126	1138	-12	-1
19	Johnson & Johnson	864	239	625	262

#	Company	2012 ($m)	2011 ($m)	Growth ($m)	Growth (%)
1	AstraZeneca	8750	9605	-855	-9
2	Novartis	7548	8405	-857	-10
3	Pfizer	7505	13437	-5932	-44
4	Sanofi	7337	8454	-1117	-13
5	Merck & Co.	6576	7174	-598	-8
6	Daiichi Sankyo	4165	4147	18	0
7	Boehringer Ingelheim	3509	3091	418	14
8	Bristol-Myers Squibb	3052	8039	-4987	-62
9	Astellas	2781	3011	-230	-8
10	GlaxoSmithKline	2377	2424	-47	-2
11	AbbVie	2301	2668	-367	-14
12	Takeda	2182	2713	-531	-20
13	Bayer	2153	1821	332	18
14	Shionogi	1476	1512	-36	-2
15	Amgen	950	808	142	18
16	United Therapeutics	907	741	166	22
17	Otsuka	854	834	20	2
18	Gilead Sciences	783	613	170	28
19	Dainippon Sumitomo Pharma	755	820	-65	-8
20	Mitsubishi Tanabe	724	777	-53	-7
21	Roche	623	511	112	22
22	The Medicines Company	558	485	73	15
23	Merck KGaA	488	552	-64	-12
24	Lilly	457	303	154	51
25	Forest Laboratories	455	348	107	31

Note: The 2013 ranking uses 2013 exchange rates for both its 2013 and 2012 values, to remove the effect of currency fluctuations. The 2012 ranking similarly uses 2012 exchange rates.

Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com